Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
160 Health International Ltd.

160 Health International Ltd. (2656.HK) Stock Overview

Explore 160 Health International Ltd.’s financial performance, market position, analyst ratings, and future outlook.

2656.HK●HKSE
HealthcareMedical - Distribution
HK$10.12
HK$0.39(4.008%)
Hong Kong Market is Open · 12:04

160 Health International Ltd. (2656.HK)

Meyka AI Score

Z

Key Financials

Market Cap3.5B
P/E RatioN/A
EPS (TTM)$-0.28
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$-8.97
3 Months$0.00
1 Year Target$0.00

2656.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of 160 Health International Ltd. (2656.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 3.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.29%
5-Day Change
-3.83%
1-Month Change
-17.01%
3-Month Change
-67.89%
6-Month Change
-87.78%
Year-to-Date (YTD) Change
-81.83%
1-Year Change
-64.39%
3-Year Change
-64.39%
5-Year Change
-64.39%
All-Time (Max) Change
-64.39%

Contact Information

https://www.91160.com
86 40 0119 1160
Building 2 Yongxin Times Square, Hong Kong, NaN, 510663

Company Facts

4,870 Employees
IPO DateSep 17, 2025
CountryCN
Actively Trading

Frequently Asked Questions